Autoimmune Diseases  >>  GW406381  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GW406381 / GSK
NCT00113308 / 2005-000158-61: COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

Completed
3
2208
Europe, Canada, US, RoW
GW406381
GlaxoSmithKline
Arthritis, Rheumatoid
09/06
09/06

Download Options